Khaldoun Kerrou - Publications

Functional Estrogen Receptor Assessment: Insights From Discordant 18 F-FES PET/CT and ER Immunohistochemistry.

Journal: Clinical nuclear medicine

Published: January 29, 2026

Renal hyperparathyroidism: preoperative detection of abnormal parathyroid glands by 18F-fluorocholine PET/CT and ultrasonography. Comparison of diagnostic performance and optimization of imaging sequence based on 159 paired examinations.

Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

Published: December 22, 2025

Comparing [18F]FDG-positron emission tomography and breast magnetic resonance imaging to predict pathological complete response and 3-year invasive disease-free survival in HER2-positive early breast cancer patients: an unplanned exploratory analysis of the PHERGain trial.

Journal: ESMO open

Published: February 28, 2025

Mpox Hepatic and Pulmonary Lesions in HIV/Hepatitis B Virus Co-Infected Patient, France.

Journal: Emerging infectious diseases

Published: October 24, 2024

18F-Fluorocholine-Positron Emission Tomography/Computerized Tomography (FCH PET/CT) Imaging for Detecting Abnormal Parathyroid Glands: Indication, Practice, Interpretation and Diagnostic Performance.

Journal: Seminars in nuclear medicine

Published: August 07, 2024

Malignant Peritoneal Mesothelioma Complicating Familial Mediterranean Fever on 18 F-FDG PET/CT.

Journal: Clinical nuclear medicine

Published: January 25, 2024

3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.

Journal: Lancet (London, England)

Published: September 29, 2023

Optimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 21, 2023

18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center.

Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

Published: March 30, 2023

18F-NaF positron emission tomography/computed tomography in voriconazole-induced periostitis.

Journal: Clinical rheumatology

Published: December 13, 2022

Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.

Journal: Future oncology (London, England)

Published: October 27, 2022

Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer - Case Report.

Journal: Clinical lung cancer

Published: July 09, 2022